Success starts with the right partner.

Our services deliver what your project needs

Our expertise lies in the development of novel dosage forms in combination with innovative analytical methods. We specialize in the development and analysis of innovative dosage forms for personalized medicine that are individually tailored to the needs of patients. In addition, we develop cannabis extracts and cannabis-containing dosage forms to meet the growing demands of the market.

Another focus of our work is the establishment of analytical methods for cannabis products to ensure their quality and safety. We are also developing advanced analytical methods for personalized medicines using near-infrared spectroscopy (NIRS), which enable precise and efficient analysis.

We are a full-service contract laboratory and offer a wide range of analytical and galenic services.

Our services include:

Analytical services

We also store test specimens as part of stability tests. To store the test specimens according to ICH, we have qualified air-conditioning units with the following controlled laboratory conditions:

We are also able to store narcotics. We can also store substances under special climatic conditions on request.

Analytics

High-quality pharmaceutical starting materials are a key factor in ensuring the safety of drug therapies. To guarantee this …

Galenic development

Galenic development is at the heart of our work – from traditional to innovative dosage forms. We provide our customers …

Narcotics analysis

Handling narcotics requires special care, the highest safety standards, and complete documentation. As a GMP-certified contract laboratory …

Cannabis analysis

Since QMEDIS Analytics was founded in March 2021, we have focused on analytics related to medical cannabis: whether in the form of …

Stability testing

The stability of pharmaceutical products is a decisive factor in their quality, efficacy, and safety. In order to meet the high regulatory requirements …

Clinical trial samples and drug manufacturing

coming soon...